Introduction
============

Systemic lupus erythematosus (SLE) is a chronic heterogeneous systemic autoimmune disease that can, in principle, affect any kind of body organ or cell, primarily in young women \[[@B1]\]. In SLE, altered immune responses may stimulate the production of autoantibodies and immune complex deposits in body organs, resulting in organ damage \[[@B2]\]. Like other autoimmune diseases, SLE has a complex pathogenesis, and the disease mechanism is still unclear; however, it is widely accepted that genetic factors could be important contributors to SLE \[[@B2][@B3]\]. Accordingly, several lines of evidence have supported that SLE may be explained by genetic factors. For instance, the concordance rate of SLE in monozygotic twins (24% to 58%) is higher than the rate in dizygotic twins (2% to 5%), and also, the disease heritability is high (\>66%) \[[@B4][@B5][@B6]\].

A number of genome-wide association studies (GWASs) have identified novel single-nucleotide polymorphisms (SNPs) associated with the risk of SLE, such as *HLA*, *PTPN22*, *STAT4*, *IRF5*, *TNFAIP3*, *BLK*, and *BANK1*, in various ethnic groups, but most of the GWASs have been performed in Caucasians \[[@B1][@B7][@B8][@B9][@B10][@B11][@B12][@B13]\]. In Korea, most of the previously reported SNPs were validated by GWASs, and potentially East Asian-specific SNPs, such as the SNPs in *ETS1*, *IKZF1*, and *SLC15A4*, were also identified \[[@B14][@B15][@B16]\]. Recently, Bentham et al. \[[@B12]\] performed a large-scale GWAS with 7,219 cases and 15,991 controls in Europeans and defined 43 SLE loci, including 10 new loci.

Among the SLE-associated loci in Bentham et al. \[[@B12]\], some of them have not been replicated in the Korean population, and others were replicated but not concluded to be associated due to a limited sample size. In this study, we aimed to replicate five SNPs that were not replicated or concluded to be association in Koreans.

Methods
=======

Study subjects
--------------

All participants were of Korean ancestry. For the replication study, 656 SLE patients (males, 11; females, 645; age \[mean ± SD\], 33.7 ± 12.1 years) were recruited from the Rheumatology Center at Seoul St. Mary\'s Hospital, The Catholic University of Korea, South Korea. All patients had been diagnosed as having SLE according to the American College of Rheumatology-revised criteria for SLE \[[@B17][@B18]\]. In addition, the allele frequencies for healthy Korean population as control were derived from the Korea Reference Genome Database (n=622). This study was performed under the approval of our institutional review board (MC12TIMI0026).

SNP genotyping
--------------

In this study, we selected five SNPs (rs1801274 in *FCGR2A* locus, rs2286672 in *PLD2* locus, rs887369 in *CXorf21* locus, rs9782955 in *LYST*, and rs3794060 in *NADSYN1*) that were identified to be associated with SLE from a previous GWAS \[[@B12]\] but have not been tested in a Korean population. Five SNPs were genotyped using the TaqMan SNP Genotyping Assay (Applied Biosystems, Foster City, CA, USA) for allelic discrimination. TaqMan polymerase chain reaction (PCR) and fluorescence measurements were performed using a ViiA 7 Real-Time PCR System (Applied Biosystems) using a 384-well plate according to the manufacturer\'s instructions.

Statistical analysis
--------------------

Chi-square test was used to estimate Hardy-Weinberg equilibrium with the genotype data of the SLE cases and controls. Significant differences in alleles and genotype frequencies between cases and controls were assessed using SPSS version 22 (IBM Corp., Armonk, NY, USA). Odds ratios (ORs) were calculated by case and control allele frequencies with 95% confidence intervals (CIs). The p-values \<0.05 were regarded as statistically significant.

Results
=======

Candidate SNP selection
-----------------------

Of the 43 SLE-associated loci identified by Bentham et al. \[[@B12]\], we narrowed down the candidate SNPs for this study per the following criteria: SNPs that had not been replicated in the Korean population, SNPs with a minor allele frequency above 5% in an East Asian population, and SNPs that were replicated in the Korean population but inconclusive owing to the limited sample size. Seven of the 43 SNPs were not replicated in the Korean population, and five of them showed a minor allele frequency above 5% in the East Asian population ([Supplementary Table 1](#S1){ref-type="supplementary-material"}). Therefore, we selected the five SNPs for a replication study in Koreans (rs1801274 in *FCGR2A* locus, rs2286672 in *PLD2* locus, rs887369 in *CXorf21* locus, rs9782955 in *LYST*, and rs3794060 in *NADSYN1*) ([Table 1](#T1){ref-type="table"}). Three of them were nonsynonymous, and the other two were intronic SNPs.

Association with SLE
--------------------

A total of 656 cases and 622 controls were enrolled and genotyped to analyze the association with SLE. Minor allele frequencies of the five SNPs in this study were similar to those in East Asians from 1000 Genomes Database ([Table 2](#T2){ref-type="table"}) \[[@B19]\], suggesting that this study group can represent the Korean population and that our genotyping was reliable. We performed an association analysis with three different genetic models: allelic, dominant, and recessive ([Table 3](#T3){ref-type="table"}).

Of the five SNPs, rs1801274 in *FCGR2A* was significantly associated with the risk of SLE in all three models, but the other four SNPs did not show a significant association. Under allelic model, the minor allele frequency of genotype G in rs1801274 was significantly higher in SLE patients (AF = 0.285) than in controls (AF = 0.24) (OR, 1.26; 95% CI, 1.06 to 1.50; p = 0.01). Also, the dominant model of minor allele in rs1801274 seems significantly associated with SLE (OR, 1.28; 95% CI, 1.02 to 1.59; p = 0.03). Under recessive model, the genotype G/G of rs1801274 was significantly associated with SLE (OR, 1.55; 95% CI, 1.01 to 2.39; p = 0.046).

Discussion
==========

SLE is a complex autoimmune disease caused by complex interactions between genetic and environmental components \[[@B4][@B20]\]. Its high heritability and relatively higher risks in siblings suggest a genetic contribution to the risk of SLE \[[@B21][@B22]\]. In this study, we aimed to replicate five SNPs that were discovered in Caucasians \[[@B12]\] but not replicated in Koreans (rs2286672 in *PLD2* locus, rs887369 in *CXorf21* locus, rs9782955 in *LYST*, and rs3794060 in *NADSYN1*) or replicated in Koreans (rs1801274 in *FCGR2A* locus) with insufficient sample size to conclude any association. Through a replication study with 656 cases and 622 controls, rs1801274 in *FCGR2A* was found to be significantly associated with SLE in Koreans. However, the other four candidate SNPs were not replicated in Koreans.

The risk allele (G) of rs1801274 in *FCGR2A* is a missense variant that changes a histidine to arginine \[[@B23]\]. The human Fcγ receptor (*FCGR*) gene family (*FCGR2A*, *FCGR2B*, and *FCGR2C*) is located on chromosome 1q23, and it is considered to be associated with the susceptibility to SLE \[[@B23][@B24]\]. Functionally, human Fcγ receptor is involved in anti-inflammatory regulation of immune responses. Another important role of human Fcγ receptor is the clearance of immune complexes \[[@B25]\]. Indeed, *FCGR* polymorphisms have been reported to be associated with the susceptibility to autoimmune diseases, including SLE \[[@B26][@B27][@B28]\]. A well-known polymorphism is the missense variant at amino acid 131 in *FCGR2A*, which decreases binding affinity to human immunoglobulin G \[[@B23][@B28][@B29]\]. The homozygosity for R131, being regarded as the low-binding allele of *FCGR2A*, is known to be associated with a 1.30-fold greater risk for the development of SLE compared with both of the other genotypes combined \[[@B30][@B31]\]. Thus, *FCGR2A*-R131 may have potential roles in causing defective immune complex clearance and increased tissue deposition, thereby leading to accelerated organ damage \[[@B30][@B32]\]. *FCGR2A* on phagocytic cells is a receptor for C-reactive protein (CRP) and the serum amyloid P (SAP) component, both acting as opsonins for nuclear antigens \[[@B33][@B34]\], and the binding between receptor and CRP or SAP might be influenced by polymorphisms \[[@B30][@B35]\], because there is a dose-response characteristic between FCGR-2A-R/H131 and the risk of SLE, with an escalation of SLE risk between RR homozygotes and RH heterozygotes \[[@B30][@B31][@B32]\]. Vigato-Ferreira et al. \[[@B27]\] examined the allelic distribution of *FCGR2A* in a Brazilian population (157 SLEs and 160 controls). They found that two polymorphisms of *FCGR2A* were associated with SLE (*FCGR2A*-R-131 and RR-131), noting that the *FCGR2A*-H-131 allele was associated with the susceptibility to arthritis and anti-DNA antibodies \[[@B27]\]. In the meta-analysis performed by Li et al. \[[@B28]\], the *FCGR2A*-R/H131 variant was associated with the development of SLE in Asians both at the allele and genotype level. Low copy number of *FCGR* genes, including *FCGR2A*-RR-131, *FCGR3B*, and the 2B.4 haplotype of *FCGR2B*, has also been reported to be associated with the susceptibility to SLE \[[@B26]\]. Other studies also reported the association between *FCGR2A* and SLE nephritis in the Korean population \[[@B36][@B37][@B38][@B39]\], demonstrating that the *FCGR2A* H131R missense variation is presented as a risk allele of SLE and SLE nephritis. However, the association was hard to conclude because of the lack of power due to the limited small sample size (73 to 300 patients).

In conclusion, in this study, we performed a replication study of five SNPs, previously known to be associated with SLE but not replicated in Koreans, with a relatively large amount of samples, demonstrating that rs1801274 in *FCGR2A* shows a nominally significant association with SLE, but the other four SNPs appear to have no association in the Korean population. Our result is supportive that *FCGR* polymorphisms may play important roles in the susceptibility to SLE in diverse populations, including Koreans.
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###### Supplementary Table 1

SNPs identified to be associated with SLE in a previous GWAS^a^ but not replicated in the Korean population

###### SNP information for allele genotyping
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SNP, single-nucleotide polymorphism.

###### Alternative allele frequencies of five SNPs in patients with SLE and controls
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SNP, single-nucleotide polymorphism; SLE, systemic lupus erythematosus; Ref./Alt., reference allele/alternative allele; All, average of entire population; AFR, African; AMR, American; EAS, East Asian; EUR, European; SAS, South Asian.

###### Genotypic association between each SNP and SLE risk in Korean SLE patients and healthy controls
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SNP, single-nucleotide polymorphism; SLE, systemic lupus erythematosus; Ref./Alt., reference allele/alternative allele; AF, alternative allele frequency; RH, number of homozygous references; HT, number of heterozygous; AH, number of homozygous alternates; OR, odds ratio; CI, confidence interval.
